Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Immune Phenotype in Glioblastoma Patients

NCT02751138 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT02751138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02751138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Immune Phenotype in Glioblastoma Patients
Lead sponsor
University of Ulm
Phase
Observational
Overall status
Completed
Start date
March 1, 2016
Completion date
January 1, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme